EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations

George Kroumpouzos iD, Patrick Treacy iD

JMIR Dermatology · 17.01.2024 · 7 · e50403

DOI: 10.2196/50403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JMIR Dermatology, online erschienen am 17.01.2024. Verfasst von George Kroumpouzos und 1 weiteren Autor:innen. Beteiligte Einrichtung: GK Dermatology, PC, South Weymouth, MA, United States. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyaluronidase (Hyal) can reverse complications of hyaluronic acid (HA) fillers, which has contributed substantially to the popularity of such procedures. Still, there are differing opinions regarding Hyal treatment, including dosage recommendations in filler complication management.

Objective

We aimed to address unanswered questions regarding Hyal treatment for HA filler complications, including timing and dosage, skin pretesting, properties of various Hyals and interactions with HA gels, and pitfalls of the treatment.

Methods

PubMed and Google Scholar databases were searched from inception for articles on Hyal therapy for filler complications. Articles were evaluated regarding their contribution to the field. The extensive literature review includes international leaders’ suggestions and expert panels’ recommendations.

Results

There are limited controlled data but increasing clinical experience with Hyal treatment. The currently used Hyals provide good results and have an acceptable safety profile. Nonemergent complications such as the Tyndall effect, noninflamed nodules, and allergic or hypersensitivity reactions should be treated with low or moderate Hyal doses. Hyal should be considered with prior or simultaneous oral antibiotic treatment in managing inflammatory nodules. Hyal may be tried for granulomas that have not responded to intralesional steroids. Emergent complications such as vascular occlusion and blindness require immediate, high-dose Hyal treatment. Regarding blindness, the injection technique, retrobulbar versus supraorbital, remains controversial. Ultrasound guidance can increase the efficacy of the above interventions.

Conclusions

Hyal is essential in aesthetic practice because it can safely treat most HA filler complications. Immediate Hyal treatment is required for emergent complications. Aesthetic practitioners should be versed in using Hyal and effective dosage protocols.

Schlagwörter

Stichwörter der Autor:innen

applicationcomplicationsdatadosagefillerhyaluronic acidhyaluronidaseinflammatoryinflammatory noduleinjectionmanagementnoduleskintherapytreatment

Autor:innen und Institutionen

  • GK Dermatology, PC, South Weymouth, MA, United States.
  • Department of Dermatology, Warren Alpert Medical School at Brown University, Providence, RI, United States.
  • Ailesbury Clinics Ltd, Dublin, Ireland.

ORCID-Profile: George Kroumpouzos, Patrick Treacy

Zitieren

APA

Kroumpouzos, G., & Treacy, P. (2024). Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatology, 7, e50403. https://doi.org/10.2196/50403

Vancouver

Kroumpouzos G, Treacy P. Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatology. 2024;7:e50403. doi:10.2196/50403

BibTeX
@article{Kroumpouzos2024,
  author = {Kroumpouzos, George and Treacy, Patrick},
  title = {Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations},
  journal = {JMIR Dermatology},
  year = {2024},
  volume = {7},
  pages = {e50403},
  doi = {10.2196/50403}
}
Kostenlos starten →